Literature DB >> 16867872

p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.

Marije M Vleugel1, David Shvarts, Elsken van der Wall, Paul J van Diest.   

Abstract

In previous studies, we noted that overexpression of hypoxia-inducible factor (HIF)-1alpha in breast cancer, especially the diffuse form, does not always lead to functional activation of its downstream genes. Transcriptional activity of HIF-1 may be repressed by p53 through competition for transcriptional coactivators such as p300. The aim of this study was therefore to explore the role of p53 and p300 in relation to overexpression of HIF-1alpha and activation of HIF-1 downstream genes in invasive breast cancer. p300 immunohistochemistry was performed in a group of 183 early-stage invasive breast cancers, and related to p53 accumulation, overexpression of HIF-1alpha, and several HIF-1 downstream genes. p300 was expressed in varying degrees in 84% of invasive breast cancers. p300 staining intensity correlated positively with HIF-1alpha expression (P = .04), p53 accumulation (P = .001), and overexpression of glucose transporter 1 (GLUT-1) (P < .001), a glucose transporter downstream target gene of HIF-1. GLUT-1 levels were significantly associated with p300 in HIF-1alpha positive patients (P = .02). p53 accumulation significantly positively correlated with carbonic anhydrase IX (CAIX)/GLUT-1 coexpression in HIF-1alpha-positive patients (P = .007). p53 accumulation/high p300 levels, the most favorable situation for HIF-1 downstream activation, were significantly associated with GLUT-1 overexpression (P = .01) and coexpression of CAIX/GLUT-1 (P = .03), compared with low p53/low p300 levels, the most unfavorable situation for HIF-1 downstream activation. p300 is a cofactor highly associated with p53 accumulation and HIF-1alpha levels in invasive breast cancer. Furthermore, low levels of p300 may explain absence of downstream effects in HIF-1alpha-overexpressing cancers, an effect that seems to be enhanced by wild-type levels of p53. This underlines the importance of p300 levels and p53 accumulation in the HIF-1-regulated response toward hypoxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867872     DOI: 10.1016/j.humpath.2006.03.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

1.  Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Authors:  Sun-Hee Kim; Dianren Xia; Sang-Wook Kim; Vijaykumar Holla; David G Menter; Raymond N Dubois
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Authors:  Narges K Tafreshi; Marilyn M Bui; Kellsey Bishop; Mark C Lloyd; Steven A Enkemann; Alexis S Lopez; Dominique Abrahams; Bradford W Carter; Josef Vagner; Stephen R Grobmyer; Stephen R Gobmyer; Robert J Gillies; David L Morse
Journal:  Clin Cancer Res       Date:  2011-10-20       Impact factor: 12.531

Review 3.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

4.  Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression.

Authors:  Yun-Ling Dou; Jia-Ping Lin; Feng-En Liu; Ling-Yan Wang; Hai-Hua Shu; Nan Jiang; Yan Xie; Qin Duan
Journal:  Tumour Biol       Date:  2014-05-02

5.  Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.

Authors:  Mariusz Koda; Luiza Kanczuga-Koda; Mariola Sulkowska; Eva Surmacz; Stanislaw Sulkowski
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

6.  Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition.

Authors:  Beverley M Dancy; Nicholas T Crump; Daniel J Peterson; Chandrani Mukherjee; Erin M Bowers; Young-Hoon Ahn; Minoru Yoshida; Jin Zhang; Louis C Mahadevan; David J Meyers; Jef D Boeke; Philip A Cole
Journal:  Chembiochem       Date:  2012-09-07       Impact factor: 3.164

7.  High Expression of p300 in Human Breast Cancer Correlates with Tumor Recurrence and Predicts Adverse Prognosis.

Authors:  Xiang-Sheng Xiao; Mu-Yan Cai; Jie-Wei Chen; Xin-Yuan Guan; Hsiang-Fu Kung; Yi-Xin Zeng; Dan Xie
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

8.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

9.  High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinoma.

Authors:  Zhi-Wei Liao; Tong-Chong Zhou; Xiao-Jun Tan; Xian-Lu Song; Yuan Liu; Xing-Yuan Shi; Wen-Jin Huang; Li-Li Du; Bo-Jun Tu; Xiao-Dan Lin
Journal:  J Transl Med       Date:  2012-05-30       Impact factor: 5.531

10.  Lysine120 interactions with p53 response elements can allosterically direct p53 organization.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  PLoS Comput Biol       Date:  2010-08-05       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.